Skip to main content

Table 3 CMR findings systemic sclerosis (SSc)

From: Evaluation of myocardial involvement in patients with connective tissue disorders: a multi-parametric cardiovascular magnetic resonance study

 

Controls (n = 20)

Patients (n = 17)

P

LV-EF (%)

66 ± 4

62 ± 16

0.48

LV-EDV (ml)

109 ± 28

105 ± 29

0.82

LV-ESV (ml)

37 ± 13

38 ± 14

0.87

LV-SV

71 ± 16

67 ± 16

0.63

LV-EDD

45 ± 5

46 ± 4

0.42

LA (cm2)

20 ± 4

20 ± 5

0.93

IVS (mm)

10 ± 2

10 ± 4

0.76

PA (mm)

24 ± 4

26 ± 8

0.81

LV mass (g)

76 ± 18

81 ± 31

0.82

LGE per patient

-

2 (12 %)

 

 Epicardial

-

-

 

 Intramural

-

2 (12 %)

 

 Transmural

-

-

 

 Subendocardial

-

-

 

% LV mass

-

1.3

 

Native T1 (ms)

962 (947–987)

1031 (1007–1075)

<0.001

Post contrast T1 (ms)

526 (508–553)

494 (474–525)

0.02

ECV (%)

25 (24–27)

31 (28–34)

<0.001

T2 (ms)

49 (48–51)

58 (54–59)

<0.001

  1. All values are n or mean ± SD or interquartile ranges
  2. CMR cardiac magnetic resonance, LV left ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EDD end-diastolic diameter, LA left atrium, IVS interventricular septum, PA pulmonary artery, LGE late gadolinium enhancement, ECV extracellular volume
Back to article page

Journal of Cardiovascular Magnetic Resonance

ISSN: 1532-429X

Contact us